1. P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: McCloskey, J.; Pullarkat, V.; Mannis, G.; Lin, T. L.; Strickland, S. A.; Fathi, A. T.; Erba, H. P.; Faderl, S.; Chakravarthy, D.; Lutska, Y.; Chandrasekaran, V.; Cheung, R. S.; Levis, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Preliminary analysis of lenalidomide maintenance after methotrexate‐temozolomide‐rituximab induction in older patients with PCNSL. (June 2017) Authors: Rubenstein, J.L.; Hwang, J.; Mannis, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE 1B RESULTS. (23rd June 2022) Authors: Daver, N. G.; Vyas, P.; Kambhampati, S.; Al Malki, M. M.; Larson, R.; Asch, A.; Mannis, G.; Chai-Ho, W.; Tanaka, T.; Bradley, T.; Jeyakumar, D.; Wang, E.; Xing, G.; Chao, M.; Ramsingh, G.; Renard, C.; Lal, I.; Zeidner, J.; Sallman, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗